Literature DB >> 22179206

Gut microbiota and its pathophysiology in disease paradigms.

Davide Festi1, Ramona Schiumerini, Chiara Birtolo, Luca Marzi, Lucia Montrone, Eleonora Scaioli, Anna Rita Di Biase, Antonio Colecchia.   

Abstract

The gut flora carries out important functions for human health, although most of them are still unknown, and an alteration of any of them, due to a condition of dysbiosis, can lead to relevant pathological implications. Commensal bacteria in the gut are essential for the preservation of the integrity of the mucosal barrier function and an alteration in the anatomic functional integrity of this barrier has been implicated in the pathophysiologic process of different diseases. The gut microflora plays a role in modulating the intestinal immune system; in fact, it is essential for the maturation of gut-associated lymphatic tissue, the secretion of IgA and the production of antimicrobial peptides. The enteric flora represents a potent bioreactor which controls several metabolic functions, even if most of them are still unknown. The main metabolic functions are represented by the fermentation of indigestible food substances into simple sugars, absorbable nutrients, and short-chain fatty acids. Furthermore, the gut microbiota exerts important trophic and developmental functions on the intestinal mucosa. This overview focuses briefly on the physiological role of the gut microbiota in maintaining a healthy state and the potential role played by disturbances of both the function and composition of the gut microbiota in determining important pathological conditions, such as irritable bowel syndrome, inflammatory bowel disease, metabolic syndrome, obesity, and cancer.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22179206     DOI: 10.1159/000332975

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  19 in total

Review 1.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

Review 2.  Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?

Authors:  Marco Castellana; Carlo Castellana; Luca Giovanella; Pierpaolo Trimboli
Journal:  Endocrine       Date:  2020-01-17       Impact factor: 3.633

3.  Profound systemic inflammatory response syndrome following non-emergent intestinal surgery in children.

Authors:  Bhani K Chawla; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2013-09       Impact factor: 2.545

Review 4.  Does microbiota composition affect thyroid homeostasis?

Authors:  Camilla Virili; Marco Centanni
Journal:  Endocrine       Date:  2014-12-17       Impact factor: 3.633

Review 5.  Nutrition of the critically ill - emphasis on liver and pancreas.

Authors:  Stig Bengmark
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

6.  Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Authors:  Faith Rohlke; Neil Stollman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

7.  Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection.

Authors:  Sitao Wu; Robert W Li; Weizhong Li; Ethiopia Beshah; Harry D Dawson; Joseph F Urban
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Intestinal alkaline phosphatase inhibits the translocation of bacteria of gut-origin in mice with peritonitis: mechanism of action.

Authors:  Wei Wang; Shan-Wen Chen; Jing Zhu; Shuai Zuo; Yuan-Yuan Ma; Zi-Yi Chen; Jun-Ling Zhang; Guo-Wei Chen; Yu-Cun Liu; Peng-Yuan Wang
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 9.  Nutrition of the critically ill — a 21st-century perspective.

Authors:  Stig Bengmark
Journal:  Nutrients       Date:  2013-01-14       Impact factor: 5.717

10.  Effects of feeding Bt MON810 maize to pigs for 110 days on peripheral immune response and digestive fate of the cry1Ab gene and truncated Bt toxin.

Authors:  Maria C Walsh; Stefan G Buzoianu; Mary C Rea; Orla O'Donovan; Eva Gelencsér; Gabriella Ujhelyi; R Paul Ross; Gillian E Gardiner; Peadar G Lawlor
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.